Zimmerman DH - Search Results

1

Vaccination by Two DerG LEAPS Conjugates Incorporating Distinct Proteoglycan (PG, Aggrecan) Epitopes Provides Therapy by Different Immune Mechanisms in a Mouse Model of Rheumatoid Arthritis.

Zimmerman DH, Mikecz K, Markovics A, Carambula RE, Ciemielewski JC, Toth DM, Glant TT, Rosenthal KS. Zimmerman DH, et al. Vaccines (Basel). 2021 May 2;9(5):448. doi: 10.3390/vaccines9050448. Vaccines (Basel). 2021. PMID: 34063326 Free PMC article.

2

Immunization with a LEAPS heteroconjugate containing a CTL epitope and a peptide from beta-2-microglobulin elicits a protective and DTH response to herpes simplex virus type 1.

Rosenthal KS, Mao H, Horne WI, Wright C, Zimmerman D. Rosenthal KS, et al. Vaccine. 1999 Feb 12;17(6):535-42. doi: 10.1016/s0264-410x(98)00231-x. Vaccine. 1999. PMID: 10075159

3

A L.E.A.P.S. heteroconjugate vaccine containing a T cell epitope from HSV-1 glycoprotein D elicits Th1 responses and protection.

Goel N, Rong Q, Zimmerman D, Rosenthal KS. Goel N, et al. Vaccine. 2003 Oct 1;21(27-30):4410-20. doi: 10.1016/s0264-410x(03)00429-8. Vaccine. 2003. PMID: 14505924

4

The L.E.A.P.S. approach to vaccine development.

Zimmerman DH, Rosenthal KS. Zimmerman DH, et al. Front Biosci. 2005 Jan 1;10:790-8. doi: 10.2741/1572. Print 2005 Jan 1. Front Biosci. 2005. PMID: 15569618 Review.

5

Vaccines: all things considered.

Rosenthal KS, Zimmerman DH. Rosenthal KS, et al. Among authors: zimmerman dh. Clin Vaccine Immunol. 2006 Aug;13(8):821-9. doi: 10.1128/CVI.00152-06. Clin Vaccine Immunol. 2006. PMID: 16893980 Free PMC article. Review. No abstract available.

6

CEL-2000: A therapeutic vaccine for rheumatoid arthritis arrests disease development and alters serum cytokine/chemokine patterns in the bovine collagen type II induced arthritis in the DBA mouse model.

Zimmerman DH, Taylor P, Bendele A, Carambula R, Duzant Y, Lowe V, O'Neill SP, Talor E, Rosenthal KS. Zimmerman DH, et al. Int Immunopharmacol. 2010 Apr;10(4):412-21. doi: 10.1016/j.intimp.2009.12.016. Epub 2010 Jan 13. Int Immunopharmacol. 2010. PMID: 20074669

7

Maturation of dendritic cell precursors into IL12-producing DCs by J-LEAPS immunogens.

Taylor PR, Paustian CC, Koski GK, Zimmerman DH, Rosenthal KS. Taylor PR, et al. Among authors: zimmerman dh. Cell Immunol. 2010;262(1):1-5. doi: 10.1016/j.cellimm.2010.01.003. Epub 2010 Feb 1. Cell Immunol. 2010. PMID: 20163792 Free PMC article.

8

J-LEAPS vaccines initiate murine Th1 responses by activating dendritic cells.

Taylor PR, Koski GK, Paustian CC, Bailey E, Cohen PA, Moore FB, Zimmerman DH, Rosenthal KS. Taylor PR, et al. Among authors: zimmerman dh. Vaccine. 2010 Aug 2;28(34):5533-42. doi: 10.1016/j.vaccine.2010.06.043. Epub 2010 Jun 25. Vaccine. 2010. PMID: 20600501

9

J-LEAPS peptide and LEAPS dendritic cell vaccines.

Rosenthal KS, Taylor P, Zimmerman DH. Rosenthal KS, et al. Among authors: zimmerman dh. Microb Biotechnol. 2012 Mar;5(2):203-13. doi: 10.1111/j.1751-7915.2011.00278.x. Epub 2011 Sep 6. Microb Biotechnol. 2012. PMID: 21895992 Free PMC article. Review.

10

LEAPS therapeutic vaccines as antigen specific suppressors of inflammation in infectious and autoimmune diseases.

Zimmerman DH, Steiner H 3rd, Carmabula R, Talor E, Rosenthal KS. Zimmerman DH, et al. J Vaccines Vaccin. 2012 Sep 20;3(5):149. doi: 10.4172/2157-7560.1000149. J Vaccines Vaccin. 2012. PMID: 23400692 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

52 results

Search Page

Filters